Author:
Luo Wenqing,Li Yuanqi,Ye Fei,Li Qiangming,Zhang Guoqing,Li Jindong,Li Xiangnan
Funder
National Natural Science Foundation of China
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference39 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Assessment of quality of life in patients with advanced non-small cell lung carcinoma treated with a combination of carboplatin and paclitaxel;Avelino;J Bras Pneumol,2015
3. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer;Yang;Cochrane Database Syst Rev,2014
4. Current treatments for advanced stage non-small cell lung cancer;Stinchcombe;Proc Am Thorac Soc,2009
5. First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors;Nguyen;Biologics,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献